rVSV-NDV treatment in the context of CD8 depletion led to tumor growth kinetics that were indistinguishable from the PBS + isotype treatment group, while PBS treatment in the CD8-depletion group led to even further enhanced tumor growth (Figure 6B). The gene discussed is CD8A; the disease is neoplasm.